Title for MeetingAbstracts
Alphabetical listing of titles
-
Virologic markers of human immunodeficiency virus (HIV) in cerebrospinal fluid (CSF) of infected children. American Pediatric Society 104th annual meeting and Society for Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
-
Virologic markers.
-
Virologic monitoring of clinical trials using the Chiron Corporation Quantiplex(TM) HIV RNA (bDNA) assay.
-
Virologic outcomes associated with a presonalized medication adherence program.
-
Virologic outcomes with didanosine-containing salvage therapy are not predicted by available genotypic HIV-1 resistance interpretation rules but by selected reverse transcriptase mutations: protective role of M184V.
-
Virologic resistance to efavirenz.
-
Virologic response in cerebrospinal fluid after initiation of antiretroviral therapy. Neuroscience of HIV Infection.
-
Virologic Response in PI-Naive HIV Infected Children Treated with Nelfinavir (BID or TID)-Containing Regimens: the Role of NFV Trough Concentration.
-
Virologic response of 12 therapy-experienced children receiving 24 weeks of nelfinavir triple therapy.
-
Virologic Response to Abacavir (ABC)/Efavirenz (EFV)/ddI + Hydroxyurea (HU) in Subjects Failing Initial NRTI + PI Therapy (NZTA4008 Study).
-
Virologic response to antiretroviral therapy among HIV-infected injection drug users.
-
Virologic Response to Antiretroviral Therapy in Chronically HIV-1-Infected, Antiretroviral-Naive Adults with Baseline Genotypic Resistance.
-
Virologic response to cessation of HAART in post-partum HIV+ women.
-
Virologic response to ddI following prolonged AZT rx. RV43 Study Group.
-
Virologic response to HAART and modeling HIV dynamics in early pediatric infection.
-
Virologic response to Indinavir (IDV), Efavirenz (EFV) and Adefovir (ADV) among patients failing Nelfinavir (NFV).
-
Virologic response-plasma drug concentration relationship in phase III study of nelfinavir mesylate (Viracept).
-
Virologic responses to a ritonavir/saquinavir containing regimen in patients who have previously failed nelfinavir.
-
Virologic success rates drop off sharply with decreasing levels of adherence to antiretroviral therapy.
-
Virologic suppression from different thymidine analogue (TA)-containing HAART regimen sequencing strategies: VIRA3001.
-
Virologic, Biochemical, and Histologic Response to Peginterferon-alpha 2b and Ribavirin among HIV/HCV Co-Infected Individuals.
-
Virologic, immunologic and clinical indicators of disease progression in a perinatal HIV cohort: the Women and Infants Transmission Study (WITS).
-
Virologic, immunologic and histologic responses to a 4-drug combination therapy in antiretroviral naive, HIV infected persons.
-
Virologic, immunologic, and clinical evaluation of a pediatric population of HIV-seroreverters.
-
Virological analysis of HIV isolates from individuals enrolled in a placebo-controlled trial of zidovudine alone, or in combination with ddI or ddC. The Protocol 34, 225-02 Collaborative Group.
-
Virological analysis of HIV-1-infected long term asymptomatic subjects.
-
Virological analysis of primary HIV-1 infection with rapid CD4 depletion.
-
VIROLOGICAL ANALYSIS OF THE BENEFIT OF A TREATMENT INTERRUPTION BEFORE SALVAGE THERAPY INCLUDING 7 TO 9 ANTI-RETROVIRAL DRUGS (GIGHAART ANRS 097).
-
Virological and clinical outcome of NNRTI-containing regimens for 1932 patients in EuroSIDA.
-
Virological and Clinical Response to Second Line Protease Inhibitor-Containing Regimens.